Pandion Therapeutics, Inc. — Form D
Pandion Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-22. The offering totals $57.6M, of which $21.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-01-22
- Form: D
- Accession: 0001727943-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $57.6M
- Amount sold: $21.6M
- Remaining: $36.0M
- Investors: 5
- Date of first sale: 2018-01-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-303791
Issuer
- Name: Pandion Therapeutics, Inc.
- CIK: 0001727943
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: C/O LABCENTRAL, CAMBRIDGE, MA, 02139
- Phone: 617-285-8822
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Anthony Coyle | Director | Cambridge, MA |
| Alan Crane | Director | Watertown, MA |
| Vikas Goyal | Director | Boston, MA |
| Mitchell Mutz | Director | Seattle, WA |
| Carlo Rizzuto | Director | Littleton, CO |
| Anthony Coyle | Executive Officer | Cambridge, MA |
| Jo Viney | Executive Officer | Cambridge, MA |
More